We are live on ! Find out more
ARA

American Renal Associates Holdings, Inc
ARA

Delisted

ARA was delisted on the 25th of January, 2021.

66 hedge funds and large institutions have $287M invested in American Renal Associates Holdings, Inc in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more capital invested

Capital invested by funds: $159M → $287M (+$129M)

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

5% more funds holding

Funds holding: 6366 (+3)

5% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 20

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
66
Holders Change
+3
Holders Change %
+4.76%
% of All Funds
1.3%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
21
Reduced
20
Closed
11
Calls
$405K
Puts
Net Calls
+$405K
Net Calls Change
+$332K
Name Holding Trade Value Shares
Change
Change in
Stake
CP
1
Centerbridge Partners
New York
$183M
VBA
2
Van Berkom & Associates
Quebec, Canada
$28M +$44.3K +5,185 +0.2%
BlackRock
3
BlackRock
New York
$12.7M -$219K -25,554 -2%
Renaissance Technologies
4
Renaissance Technologies
New York
$10.8M +$784K +91,725 +10%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$8M -$26.8K -3,139 -0.4%
Vanguard Group
6
Vanguard Group
Pennsylvania
$7.14M +$106K +12,378 +2%
WIC
7
Whitegate Investment Counselors
New Hampshire
$6.16M
JP Morgan Chase
8
JP Morgan Chase
New York
$4.14M -$1.77M -207,054 -34%
State Street
9
State Street
Massachusetts
$3.63M +$370K +43,296 +14%
Wells Fargo
10
Wells Fargo
California
$3.29M +$1.15M +134,543 +74%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$2.35M -$40.9K -4,782 -2%
Northern Trust
12
Northern Trust
Illinois
$2.25M +$102K +11,983 +6%
AGA
13
Altrinsic Global Advisors
Connecticut
$1.56M -$599K -70,000 -32%
Charles Schwab
14
Charles Schwab
California
$937K +$8.47K +990 +1%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$892K -$9.62K -1,125 -1%
California Public Employees Retirement System
16
California Public Employees Retirement System
California
$778K -$139K -16,200 -18%
Morgan Stanley
17
Morgan Stanley
New York
$744K +$520K +60,828 +555%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$728K -$10.9K -1,276 -2%
Squarepoint
19
Squarepoint
New York
$712K +$587K +68,639 New
Nuveen
20
Nuveen
North Carolina
$641K -$3.04K -356 -0.6%
SO
21
STRS Ohio
Ohio
$624K -$71.8K -8,400 -12%
DekaBank Deutsche Girozentrale
22
DekaBank Deutsche Girozentrale
Germany
$592K +$510K +59,695 New
BCM
23
Bridgeway Capital Management
Texas
$556K +$458K +53,600 New
RJA
24
Raymond James & Associates
Florida
$507K +$73.4K +8,589 +21%
Invesco
25
Invesco
Georgia
$480K +$55.4K +6,481 +16%

ARA Hedge Fund Activity: Q4 2019 in Review

66 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in American Renal Associates Holdings, Inc (ARA) for Q4 2019, worth a combined $287M — up 81% from $159M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ARA positions and 11 closed out — a net gain of 3 holders — while 21 added to existing stakes and 20 trimmed.

The largest buyer was Wells Fargo, adding an estimated $1.15M. The largest seller was Federated Hermes, cutting an estimated $1.89M.

  • 66 institutional investors held American Renal Associates Holdings, Inc (ARA) as of Q4 2019, up from 63 in Q3 2019.
  • Funds reported $287M of American Renal Associates Holdings, Inc stock for Q4 2019, up 81% quarter-over-quarter.
  • 14 funds opened new American Renal Associates Holdings, Inc positions in Q4 2019 and 11 closed out, a net change of +3 holders.
  • The largest American Renal Associates Holdings, Inc buyer in Q4 2019 was Wells Fargo, an estimated $1.15M added.
  • The largest American Renal Associates Holdings, Inc seller in Q4 2019 was Federated Hermes, an estimated $1.89M sold.

Based on aggregated 13F filings for Q4 2019.